| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |